Abstract
Abstract: Oncologists and surgeons managing patients with colorectal cancer need to appreciate that approximately 60% of their patients are >70 years of age, more than 40% are >75 years and that these proportions may increase further in the future. Many of these patients will have co-morbidity and frailty issues. In an era of increased availability of anti-tumoural agents and expanding treatment strategies, elderly patients present a challenging therapeutic scenario. What may be considered “standard” management for the general population does not necessarily apply to this group where evidence-based data are lacking.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
